Mechanisms and management of multimorbidity in patients with COPD

Multimorbidity, defined as the presence of two or more chronic conditions, represents a significant challenge in the management of COPD, a complex and highly prevalent disease. The coexistence of chronic conditions such as cardiovascular or metabolic diseases increases the frequency and severity of COPD exacerbations, complicates treatment decisions and worsens patient outcomes. These coexisting diseases may share underlying mechanisms, including systemic inflammation, oxidative stress and risk factors such as smoking, which accelerate disease progression. In this review, we discuss the prevalence and clinical significance of multimorbidity in COPD, with a focus on shared risk factors, the pathophysiological mechanisms and the impact on outcomes. Additionally, we examine current disease management strategies for COPD and multimorbidity, highlighting the need for a multidisciplinary, personalised approach, and discuss the role of biomarkers in coexisting conditions.

Authors

Institutions

Publication Details

Journal
European Respiratory Journal
Published
2026-11-19
DOI
https://doi.org/10.1183/13993003.02435-2025
Primary Topic
Chronic Obstructive Pulmonary Disease (COPD) Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Mechanisms and management of multimorbidity in patients with COPD

Vijay K. T. Alagappan, Stephanie A. Christenson, Gerard J. Criner, Claus Franz Vogelmeier et al.
European Respiratory Journal
Chronic Obstructive Pulmonary Disease (COPD) Research
article

Mechanisms and management of multimorbidity in patients with COPD

Vijay K. T. Alagappan, Stephanie A. Christenson, Gerard J. Criner, Claus Franz Vogelmeier, Jigna Heble, Fuqiang Wen
article en

Abstract

Multimorbidity, defined as the presence of two or more chronic conditions, represents a significant challenge in the management of COPD, a complex and highly prevalent disease. The coexistence of chronic conditions such as cardiovascular or metabolic diseases increases the frequency and severity of COPD exacerbations, complicates treatment decisions and worsens patient outcomes. These coexisting diseases may share underlying mechanisms, including systemic inflammation, oxidative stress and risk factors such as smoking, which accelerate disease progression. In this review, we discuss the prevalence and clinical significance of multimorbidity in COPD, with a focus on shared risk factors, the pathophysiological mechanisms and the impact on outcomes. Additionally, we examine current disease management strategies for COPD and multimorbidity, highlighting the need for a multidisciplinary, personalised approach, and discuss the role of biomarkers in coexisting conditions.

European Respiratory Journal
University of California, San Francisco (US), Sichuan University (CN), Morristown Medical Center (US), West China Hospital of Sichuan University (CN), Progenics Pharmaceuticals (United States) (US), German Center for Lung Research (DE), C3I (United States) (US), Temple University (US)
Chronic Obstructive Pulmonary Disease (COPD) Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon